Genetics In Neurodegenerative Disorder

Neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis, are medical conditions that cause progressive deterioration of the integrity of the neurons, leading to motor deficits and cognitive impairments. Genetic mutations have been identified as important causes in the pathogenesis of these neurological diseases. Recent advances in the field of genetics have enabled the identification of numerous genetic loci, which have been linked to various neurodegenerative disorders. These genetic mutations or sequence variations occur in genes that regulate nerve cell survival, function, or transmission. For example, mutations in the parkin gene are associated with autosomal recessive juvenile parkinsonism, while mutations in the PSEN1 and PSEN2 genes are associated with early-onset Alzheimer’s Disease. In addition to the direct effect of gene mutations, recent development of genome-wide association studies (GWAS) has revealed many additional genetic loci, which may contribute to a variety of neurological disorders such as autism and schizophrenia. For instance, GWAS analyses have revealed that some of these genetic loci could play a role in an increased risk for Alzheimer’s Disease and parkinsonism. The involvement of genetics in neurodegenerative disorders is multifactorial, and their impact cannot be fully comprehended. In some cases, mutations can lead to a loss or gain of function of proteins, while in other cases the variants may only affect the expression of the corresponding gene, thereby leading to disease progression. In order to gain a better understanding of the mechanisms behind these disorders, further genetic investigations must be performed in order to identify additional genetic loci that may be involved in the pathogenesis of these conditions. In conclusion, genetic mutations have been identified as major risk factors for a variety of neurological disorders. A better understanding of the genetics of neurodegenerative diseases would provide us with vital additional insight into the mechanisms behind these conditions and will enable us to better assess and plan preventive and therapeutic strategies.